Continuous Passive Motion Versus Heterotopic Ossification (CPMversusHO)
Traumatic Brain Injury, Spinal Cord Injuries, Stroke
About this trial
This is an interventional prevention trial for Traumatic Brain Injury focused on measuring Ossification, Heterotopic, continuous passive motion (CPM), zoledronic acid, range of motion (ROM), PROPHYLAXIS
Eligibility Criteria
Inclusion Criteria: Patients with stabilized medical condition suffering from neurological insult either traumatic brain injury (TBI), stroke, or Spinal Cord Injury. A negative triplex ultrasound in order to rule out deep venous thrombosis (DVT) A positive three-phase bone scan with Tc99. (Will be obtained as soon as HO symptoms are onset.) Patients with verified HO formation on the knee or hip joint will undergo a CT to show the extent of the lesion. Exclusion Criteria: Life-threatening conditions that render Continuous passive motion (CPM) application difficult. HO detected in another location than the hip or knee joint. Concomitantly presence of other fractures that will interfere with the bone alkaline phosphatase (AP) level. Patients not reacting to painful stimuli
Sites / Locations
- Department of Physical and Rehabilitation MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Continuous passive motion (CPM)
Physiotherapy (PT)
10 ICU patients receiving CPM at HO joints that continuously stretches slowly the joint passively at a constant velocity in a painless range and for a substantial amount of time until there is evidence both laboratory (bone alkaline phosphatase) and radiographically (CT), that osteogenesis has entered a quiescent state. Conventional PT will also be performed. Plus a single dose of zoledronic acid (Aclasta) once the diagnosis of HO is made.
10 ICU patients receiving the conventional PT, plus a single dose of zoledronic acid (Aclasta) once the diagnosis of HO is made.